Impact of Proposed Indirect Cost Cap on Biomedical Research Funding

Role of the National Science Foundation (NSF)

• 💡 The NSF is highlighted as a crucial funding agency exclusively supporting basic research, distinct from other government bodies.
• 🔬 NSF-funded curiosity-driven research has led to significant breakthroughs, including CRISPR gene editing and advancements in imaging technologies.
• 🎓 The NSF's Graduate Research Fellowship program is praised for identifying and funding the best students across America, fostering decades of discovery.

Understanding Indirect Costs

• 📌 Indirect costs, also known as facilities and administrative (F&A) costs, cover essential operational expenses like lab space, sophisticated equipment, HR, and federal regulation compliance.
• 💰 Independent research institutions, lacking large endowments or tuition revenue, rely on the current indirect cost reimbursement system to cover these real operational costs.

Proposed Cap's Impact on Research Institutions

• ⚠️ The administration's proposed across-the-board 15% cap on indirect costs is seen as a significant threat to biomedical research.
• 📉 Hermann Haller of MDI Biological Laboratory states that this cap endangers their work and that of other independent research institutions, potentially preventing participation in lifesaving research and biomedical breakthroughs.
• 🗣️ While open to discussions for improvement, the proposed cap is viewed as unsustainable for institutions dependent on the current indirect cost reimbursement system.